Emcure Pharmaceuticals Ltd Cash Flow Reinvestment Rate
Emcure Pharmaceuticals Ltd cash flow reinvestment rate. Emcure Pharmaceuticals Ltd (EMCURE) has a Cash Flow Reinvestment Rate of 0.50x as of September 2025, reinvesting Rs1.29 Billion (capex Rs1.29 Billion ) from operating cash flow of Rs2.56 Billion. See Emcure Pharmaceuticals Ltd (EMCURE) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Emcure Pharmaceuticals Ltd (2022–2026)
Cash flow reinvestment rate of Emcure Pharmaceuticals Ltd from 2022 to 2026. Historical reinvestment intensity for Emcure Pharmaceuticals Ltd across 5 annual periods. Explore EMCURE cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Emcure Pharmaceuticals Ltd Cash Flow Reinvestment Rate by Year (2022–2026)
Emcure Pharmaceuticals Ltd cash flow reinvestment rate by year from 2022 to 2026. Year-by-year capital reinvestment analysis for Emcure Pharmaceuticals Ltd. For the full cash flow conversion analysis, see Emcure Pharmaceuticals Ltd (EMCURE) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.42x | Rs3.61 Billion | Rs8.51 Billion | Rs3.61 Billion | ▼ -27.9% |
| 2025 | 0.59x | Rs5.01 Billion | Rs8.52 Billion | Rs4.07 Billion | ▲ +54.8% |
| 2024 | 0.38x | Rs4.17 Billion | Rs10.97 Billion | Rs3.07 Billion | ▼ -40.2% |
| 2023 | 0.63x | Rs4.74 Billion | Rs7.47 Billion | Rs4.03 Billion | ▼ -3.0% |
| 2022 | 0.65x | Rs5.03 Billion | Rs7.68 Billion | Rs3.97 Billion | — |